logo

ICUI

ICU Medical·NASDAQ
--
--(--)
--
--(--)
0.94 / 10
Underperform

ICU Medical's fundamental standing is weak, scoring only 0.9/10. Key liabilities include low revenue-to-market value and net-income-to-revenue ratios, which place the company in less favorable performance groups. Historical back-tests for these factors show negative or marginal monthly returns, reinforcing the caution. Strengths exist in cash-related metrics and net profit margin relative to total profit, but these are insufficient to offset the core operational inefficiencies. The firm's interest coverage ratio is adequate, yet overall asset and income quality remain sub-par, leading to an underperform rating.

Fundamental(0.94)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value0.42
Score1/3
Weight26.53%
1M Return-1.83%
ROA (%)
Value0.40
Score1/3
Weight9.71%
1M Return-0.54%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight26.80%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight37.84%
1M Return-2.55%
Cash-UP
Value1.19
Score2/3
Weight65.33%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value0.53
Score1/3
Weight9.71%
1M Return-0.54%
Interest coverage ratio (EBIT / Interest expense) (%)
Value1.35
Score2/3
Weight30.22%
1M Return-1.95%
Asset-MV
Value-0.50
Score3/3
Weight-66.79%
1M Return3.31%
Cash-MV
Value-0.36
Score2/3
Weight-67.50%
1M Return3.31%
Net profit / Total profit (%)
Value76.39
Score2/3
Weight28.14%
1M Return-1.71%
Is ICUI undervalued or overvalued?
  • ICUI scores 0.94/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.80% ROE, -0.32% net margin, -516.94 P/E ratio, 1.79 P/B ratio, and 93.20% earnings growth, these metrics solidify its Underperform investment rating.